Prophylactic mastectomy rare among high-risk women

Article

It is relatively uncommon for women at high risk for breast cancer, but without diagnosed disease, to opt for prophylactic mastectomy, but women diagnosed with breast cancer are increasingly likely to undergo contralateral mastectomy, according to a study published online Sept. 28 in Cancer.

Contralateral mastectomy for women with diagnosed breast cancer increasing



MONDAY, Sept. 28 (HealthDay News)-It is relatively uncommon for women at high risk for breast cancer, but without diagnosed disease, to opt for prophylactic mastectomy, but women diagnosed with breast cancer are increasingly likely to undergo contralateral mastectomy, according to a study published online Sept. 28 in

Cancer

.

Colleen C. McLaughlin, Ph.D., of New York State Department of Health in Troy, and colleagues analyzed discharge and cancer registry data in the state of New York from 1995 to 2005 and identified 6,275 women who underwent prophylactic mastectomy.

While 19 percent of the women had no identifiable personal history of breast cancer, 81 percent had been diagnosed with the disease. Of these, 84 percent had invasive breast cancer and 16 percent had ductal carcinoma in situ, the researchers discovered. Over time, women with a diagnosis of breast cancer were more likely than those without such a diagnosis to undergo contralateral prophylactic mastectomy, the investigators note.

"Reports in the general media regarding prophylactic mastectomies among young women at high risk of breast cancer are fairly common," the authors wrote. "Because population-based data on the number of high-risk women are not available, we cannot calculate a rate of prophylactic surgery; however, given that New York is home to approximately nine million women, it appears from the current analysis that the surgery is actually fairly uncommon, whereas the use of contralateral mastectomy in women with breast cancer is increasing."

The authors reported partial financial support from the U.S. Centers for Disease Control and Prevention.

Abstract

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.